leftspacer middlespacer rightspacer
Media Menu
Featured Material


MAPS BULLETIN
MAPS Bulletin Summer 2014: Research Edition
 
Media > Recent and Archival
March 22, 2012

Tim Leary’s Floatation Tank For Sale

By: David Pescovitz

Boing Boing

The “floatation tank,” sometimes called the isolation or sensory deprivation tank, was developed in the mid-1950’s by psychoanalyst and consciousness researcher John C. Lilly, M.D. Lilly used the isolation tank to test the relationship between the mind and external reality. After extensive experimentation with the tank, he came to explore it for many potential applications, ranging from increasing creative problem-solving ability to facilitating meditation and prayer.

This tank was originally owned by the controversial psychedelic researcher Timothy Leary. In February of 1996, Dr. Lilly and the Samadhi Tank Company delivered the tank to Dr. Leary to help ease his end-of-life suffering. The current owner is Dean Chamberlain, photographer and renowned visionary artist who has generously agreed to share proceeds from the sale with MAPS to benefit of psychedelic and medical marijuana research and education.

Click here to view the eBay listing.


Originally appearing here.

You can own Timothy Leary’s sensory deprivation tank! The Samadhi Tank Company delivered the tank to Tim the month before he died. I don’t know how often Tim used it, but I remember seeing it in the corner of his bedroom. Tim’s tank is on eBay for a Buy It Now price of $20,000 with the proceeds going to the nonprofit Multidisciplinary Association for Psychedelic Studies. In the late 1980s, I experimented with a similar tank a few times myself but stopped because it was causing me to de-evolve into a primitive man. Your mileage may vary. “Samadhi Floatation Tank Originally Owned by Timothy Leary”.


Back to MAPS in the Media

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.